Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Nephrology and Urology Incontinence Devices Market Overview (2022-2032)

[250 Pages Report] The nephrology and urology incontinence devices market is expected to record a CAGR of 4.1% during the forecast period, up from US$ 38 Billion in 2021 to reach a valuation of US$ 46.4 Billion by 2026.

Report Attributes Details
Estimated Base Year Value (2021) US$ 38 Billion
Anticipated Forecast Value (2026) US$ 46.4 Billion
Projected Growth Rate (2022 to 2032) 4.1% CAGR

Sales of nephrology and urology incontinence devices are expected to rise due to government measures to support R&D in the field.

For instance, during the virtual KidneyX Summit in July 2020, the United States Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) revealed the six winners of the US$ 3 million KidneyX: Redesign Dialysis Phase 2 competition.

In addition to this, demand for nephrology and urology incontinence devices has also increased due to the focused concentration on providing digital solutions during the Covid-19 pandemic.

The global nephrology and urology devices market is predicted to increase due to the increasing geriatric population.

The sales of nephrology and urology incontinence devices are projected to be hampered by high installation costs for equipment such as lithotripters and sophisticated machines and further projected to contribute to the growth of nephrology and urology incontinence devices market share.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Dynamics to the Nephrology and Urology Incontinence Devices Market Share?

Presently, the sales of nephrology and urology incontinent devices are primarily driven by the rising prevalence of chronic kidney disease (CKD), Benign Prostatic Hyperplasia (BPH) and End Stage Renal Disease (ESRD).

Growing awareness programs about these particular diseases and personal hygiene among patients will result in the increased demand for nephrology and urology incontinent devices in the forecast years.

Also, with the increase in healthcare expenditure and favorable reimbursement in the developed countries, the sales of nephrology and urology incontinent devices are expected to have a healthy growth.

Rising incidence rates and health consequences of urological disorders result in the growing demand for nephrology and urology incontinence devices treatments to manage them, boosting the sales of neurology and urology incontinence devices.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which is the Leading Region in the Nephrology and Urology Incontinence Devices Market?

Depending on geographic regions, the nephrology and urology incontinence devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America and Europe are expected to capture the most significant sales of nephrology and urology incontinence devices, followed by Asia Pacific countries where the demand for nephrology and urology incontinence devices market is expected to grow due to increased awareness of personal hygiene and an increase in disposable income of middle-class consumers.

Who are the Key Players in the Nephrology and Urology Incontinence Devices Market?

Some of the key participating players in the nephrology and urology incontinence devices market are Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimberly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.

Increased demand for nephrology and urology incontinence devices is predicted to rise due to a growing desire for minimally invasive and non-invasive treatment approaches.

Recent Developments

  • The FDA granted Baxter International Inc. (US) 510(k) certification for their Homechoice Claria automated peritoneal dialysis system with the Sharesource connection platform in November 2020.
  • In May of this year, Fresenius Medical Care AG & Co. KGaA (Germany) announced the opening of a new distribution facility in Knoxville, Tennessee. This extension will make it easier to get goods for in-center hemodialysis therapy.
  • Fresenius Medical Care AG & Co. KGaA (Germany) bought NxStage Medical, Inc. (US) in February 2019 to expand its renal and critical care product range.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Scope of Report

Report Attributes Details
Growth Rate CAGR of 4.1% from 2022 to 2032
Base Year for Estimation 2021
Historical Data 2015 to 2020
Forecast Period 2022 to 2032
Quantitative Units Revenue in USD Million, Volume in Kilotons and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Regions Covered
  • North America
  • Latin America
  • Europe
  • APAC
  • Middle East and Africa
Key Countries Profiled
  • USA
  • Canada
  • Mexico
  • Brazil
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • GCC
  • Israel
  • South Africa
  • Central Africa
Key Companies Profiled
  • Baxter International Inc.
  • C. R. Bard, Inc.
  • Coloplast UK Ltd.
  • Unicharm Corporation
  • Kimerly-Clark Corporation
  • Hollister Inc.
  • ConvaTec
  • B.Braun Melsungen AG
  • SCA (Svenska Cellulosa Aktiebolaget)
Customization Scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs.

Key Segments

By Type:

  • Dialysis Devices and Equipment
  • Urinary Stone Treatment Devices and Equipment
  • Urinary Incontinence & Pelvic Organ Prolapse Devices and Equipment
  • Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment
  • Endoscopy Devices and Equipment

By End User:

  • Hospitals and Clinics
  • Diagnostic Laboratories

By Type Of Expenditure:

  • Public
  • Private

By Product:

  • Instruments/Equipment
  • Disposables

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

What is the Growth Outlook for the Nephrology and Urology Incontinence Devices Market?

The nephrology and urology incontinence devices market are predicted to register a CAGR of 4.1% during the forecast period.

Who are the Key Players in the Nephrology and Urology Incontinence Devices Market?

Key players holding substantial nephrology and urology incontinence devices market share includes Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimerly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.

What is the Future of the Nephrology and Urology Incontinence Devices Market?

As per the analysis, the nephrology and urology incontinence devices market share are likely to be US$ 46.4 Bn by 2026.

Which is the Key Driver in the Nephrology and Urology Incontinence Devices Market?

Demand for nephrology and urology incontinence devices market is likely to rise on the back of increasing due to the focused concentration on providing digital solutions during Covid-19 pandemic and the increasing geriatric population.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Bn) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Penile Compression Device

        5.3.2. Pessary

        5.3.3. Urethral Insert

        5.3.4. Artificial Urinary Sphincter

        5.3.5. Bladder Neck Support Device

        5.3.6. Urine Seal

        5.3.7. Absorbent Products

        5.3.8. Catheters

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

   Deep-dive segmentation will be available in the sample on request

6. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Bn) Analysis By Type, 2017-2021

    6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Type, 2022-2032

        6.3.1. Stress Incontinence

        6.3.2. Urge incontinence

        6.3.3. Overflow Incontinence

        6.3.4. Functional Incontinence

        6.3.5. Mixed Incontinence

    6.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Type, 2022-2032

   Deep-dive segmentation will be available in the sample on request

7. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Bn) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Specialty Clinics

        7.3.3. Homecare Settings

        7.3.4. Nursing Homes

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

   Deep-dive segmentation will be available in the sample on request

8. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia & Pacific

        8.3.6. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.K.

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Type

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Type

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Type

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Type

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product Type

        11.2.3. By Type

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Type

        11.3.4. By End User

    11.4. Key Takeaways

12. East Asia Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Product Type

        12.2.3. By Type

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Type

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia & Pacific Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Thailand

            13.2.1.3. Indonesia

            13.2.1.4. Malaysia

            13.2.1.5. Singapore

            13.2.1.6. Australia

            13.2.1.7. New Zealand

            13.2.1.8. Rest of South Asia & Pacific

        13.2.2. By Product Type

        13.2.3. By Type

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Type

        13.3.4. By End User

    13.4. Key Takeaways

14. MEA Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product Type

        14.2.3. By Type

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Type

        14.3.4. By End User

    14.4. Key Takeaways

15. Key Countries Nephrology and Urology Incontinence Devices Market Analysis

    15.1. U.K.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Product Type

            15.1.2.2. By Type

            15.1.2.3. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Product Type

            15.2.2.2. By Type

            15.2.2.3. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Product Type

            15.3.2.2. By Type

            15.3.2.3. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Product Type

            15.4.2.2. By Type

            15.4.2.3. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Product Type

            15.5.2.2. By Type

            15.5.2.3. By End User

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Product Type

            15.6.2.2. By Type

            15.6.2.3. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Product Type

            15.7.2.2. By Type

            15.7.2.3. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Product Type

            15.8.2.2. By Type

            15.8.2.3. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Product Type

            15.9.2.2. By Type

            15.9.2.3. By End User

    15.10. China

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Product Type

            15.10.2.2. By Type

            15.10.2.3. By End User

    15.11. Japan

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Product Type

            15.11.2.2. By Type

            15.11.2.3. By End User

    15.12. South Korea

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Product Type

            15.12.2.2. By Type

            15.12.2.3. By End User

    15.13. India

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Product Type

            15.13.2.2. By Type

            15.13.2.3. By End User

    15.14. Thailand

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Product Type

            15.14.2.2. By Type

            15.14.2.3. By End User

    15.15. Indonesia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Product Type

            15.15.2.2. By Type

            15.15.2.3. By End User

    15.16. Malaysia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Product Type

            15.16.2.2. By Type

            15.16.2.3. By End User

    15.17. Singapore

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Product Type

            15.17.2.2. By Type

            15.17.2.3. By End User

    15.18. Australia

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Product Type

            15.18.2.2. By Type

            15.18.2.3. By End User

    15.19. New Zealand

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Product Type

            15.19.2.2. By Type

            15.19.2.3. By End User

    15.20. GCC Countries

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Product Type

            15.20.2.2. By Type

            15.20.2.3. By End User

    15.21. South Africa

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Product Type

            15.21.2.2. By Type

            15.21.2.3. By End User

    15.22. Israel

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Product Type

            15.22.2.2. By Type

            15.22.2.3. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product Type

        16.3.3. By Type

        16.3.4. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Becton, Dickinson and Company

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. UROMED Kurt Drews KG

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Stryker Corporation

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. B. Braun Melsungen AG

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Boston Scientific Corporation

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Cook Medical LLC

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. CooperSurgical, Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Medgyn Products, Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Bioderm Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Thomas Medical, Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

        17.1.11. Essity Hygiene and Health AB

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

        17.1.12. ZEPHYR SURGICAL IMPLANTS SÀRL

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

        17.1.13. Coloplast Corp.

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

        17.1.14. Femeda Ltd.

            17.1.14.1. Overview

            17.1.14.2. Product Portfolio

            17.1.14.3. Profitability by Market Segments

            17.1.14.4. Sales Footprint

            17.1.14.5. Strategy Overview

                17.1.14.5.1. Marketing Strategy

        17.1.15. Domtar Corporation

            17.1.15.1. Overview

            17.1.15.2. Product Portfolio

            17.1.15.3. Profitability by Market Segments

            17.1.15.4. Sales Footprint

            17.1.15.5. Strategy Overview

                17.1.15.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Urology Imaging Systems Market

Published : July 2022

Explore Healthcare Insights

View Reports

Nephrology and Urology Incontinence Devices Market